The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
We focus on a number of topic areas identified by state health policy leaders as important to population health.
The Center for Evidence-based Policy at Oregon Health & Science University is a national leader in evidence-based decision making and policy design.
Keep up with news and updates from the Milbank Memorial Fund. Get the latest from thought leaders, including Christopher F. Koller, president of the Fund.
We publish The Milbank Quarterly, as well as reports and issues briefs on topics important to population health.
December 2009 (Volume 87)
John Appleby is chief economist at the King’s Fund and visiting professor in the Department of Economics at City University, London. After obtaining his master’s degree in health economics at the University of York in 1981, he worked in the National Health Service in Birmingham and London as a health economist before managing research for the National Association of Health Authorities and subsequent senior lecturer positions at the University of Birmingham and the University of East Anglia. In addition to his economic research and policy work at the King’s Fund, he has acted as an adviser to the UK Department of Health and the House of Commons Health Select Committee.
Wade M. Aubry is a physician and an associate clinical professor in the Department of Medicine and Institute for Health Policy Studies at the University of California, San Francisco. His research and policy interests focus on technology assessment, comparative effectiveness, and health insurance coverage. As a former health plan and Medicare medical director, he has had extensive experience in translating research into policy, and he has served on numerous national advisory committees for the Centers for Medicare and Medicaid Services, the Agency for Healthcare Research and Quality, the National Cancer Institute, and the Institute of Medicine. He is also co-author of a comprehensive case study on the rise and fall of a controversial cancer treatment entitled False Hope: Bone Marrow Transplantation for Breast Cancer (Oxford University Press 2007).
Pippa Bark is principal research fellow at the Centre for Health Informatics and Multiprofessional Education at University College London (UCL), with a background in psychology and clinical risk management. Her current research projects and writing include compiling a qualitative analysis of interviews concerning poorly performing doctors and how to improve them, supervising master’s dissertations on patient safety linked to informatics, and developing patient safety training materials for complementary medicine practitioners. She is currently co-editing a book proposal on patient safety, legal policy, and practice in collaboration with John Tingle at the University of Nottingham. Bark runs a patient safety module and master’s dissertation program and previously designed and ran postgraduate programs in clinical risk management, including a master’s degree, diploma, and certificate at UCL.
Adalsteinn (Steini) D. Brown currently serves as an assistant deputy minister of strategy in the Ontario Ministry of Health and Long-Term Care. In addition, he is an assistant professor in the Department of Health Policy, Management and Evaluation and on the faculty of medicine at the University of Toronto. He received his DPhil from the University of Oxford, was a Rhodes Scholar, and was named one of Canada’s Top Forty under Forty in 2003.
Thomas C. Buchmueller is the Waldo O. Hildebrand Professor of Risk Management and Insurance at the University of Michigan’s Stephen M. Ross School of Business. He also holds an appointment in the Department of Health Management and Policy at the University of Michigan School of Public Health and is a research associate of the National Bureau of Economic Research. He has a PhD in economics from the University of Wisconsin. His research focuses primarily on the economics of health insurance and related public policy issues.
Kalipso Chalkidou is director of the National Institute for Health and Clinical Excellence’s (NICE) international program, working with governments and governmental agencies abroad interested in the NICE model of using evidence to inform health policy and practice. Between 2007 and 2008, she spent a year in the United States as a Harkness Fellow, studying conditional coverage schemes for expensive new technologies at the Center for Medical Technology Policy and government drug pricing policies at the Johns Hopkins Bloomberg School of Public Health. Chalkidou worked as a surgical trainee in National Health Service hospitals in Newcastle and Cambridge. She has a doctorate in molecular biology from the University of Newcastle upon Tyne and an MD (Hons) from the University of Athens Medical School and is an honorary lecturer at the London School of Hygiene and Tropical Medicine and a visiting faculty member at the Johns Hopkins Berman Institute of Bioethics.
Janet M. Coffman is an assistant professor in the Philip R. Lee Institute for Health Policy Studies and the Department of Family and Community Medicine at the University of California, San Francisco. She serves as principal analyst for medical effectiveness for the California Health Benefits Review Program, a program of the University of California that analyzes health insurance benefit mandate bills for the California legislature. Her research interests include health insurance, the health care workforce, and management of asthma and other chronic illnesses.
Ruth R. Faden is the Philip Franklin Wagley Professor of Biomedical Ethics and director of the Berman Institute of Bioethics at Johns Hopkins University. She is also a senior research scholar at the Kennedy Institute of Ethics at Georgetown University. Faden is the author and editor of many books and articles on biomedical ethics and health policy, including Social Justice: The Moral Foundations of Public Health and Health Policy (Oxford University Press 2006), A History and Theory of Informed Consent (Oxford University Press 1986), and HIV, AIDS and Childbearing: Public Policy, Private Lives (Oxford University Press 1996). Faden is a member of the Institute of Medicine and a fellow of the Hastings Center and the American Psychological Association. She has served on numerous national advisory committees and commissions, including the President’s Advisory Committee on Human Radiation Experiments, which she chaired. Faden holds a BA from the University of Pennsylvania, an MA in general studies in humanities from the University of Chicago, and an MPH and a PhD from the University of California, Berkeley.
Dana P. Goldman holds the Norman Topping Chair in Medicine and Public Policy in the Schools of Pharmacy and Policy, Planning, and Development at the University of Southern California. Until the fall of 2009, he held RAND’s Chair in Health Economics and directed RAND’s program in health economics, finance, and organization. He is also an adjunct professor of health services and radiology at the University of California, Los Angeles. He is a member of the Congressional Budget Office’s panel of health advisers. Goldman is a nationally recognized health economist influential in both academic and policy circles. He is the author of over one hundred articles and book chapters, including articles in some of the most prestigious medical, economic, health policy, and statistics journals.
Trisha Greenhalgh is professor of primary health care at University College London. Her research interests include the study of complex change in health care and developing new methodologies for systematic reviews.
Mi-Kyung Hong is a research associate at the Philip R. Lee Institute for Health Policy Studies of the University of California, San Francisco, and a member of the California Health Benefits Review Program’s medical effectiveness review team. She conducts research that responds to requests from the California legislature to provide independent analysis of the medical, financial, and public health impacts of proposed health insurance benefit mandates and repeals in California. Hong received a BA from Columbia University and an MPH from the University of Michigan School of Public Health. She has co-authored tobacco control publications, examining tobacco industry research and its interpretation and dissemination. She has analyzed research ties, industry-sponsored publications, and industry involvement in the peer-review process.
Jonathon P. Leider is a doctoral student in bioethics and health policy at the Johns Hopkins Bloomberg School of Public Health. He received his BS in genetics, cell biology and development and his BA in philosophy from the University of Minnesota. Beyond applied topics like pandemic preparedness, his research interests lie broadly in the areas of social justice issues related to public health, science, and technology development.
Jonathan Lomas was the inaugural chief executive officer (for a decade until 2007) of the Canadian Health Services Research Foundation, an independent not-for-profit organization dedicated to the support of evidence-informed decision making in the health sector. He is now semi-retired and works internationally and in Canada as an occasional consultant on health evidence. The main focus of his career is the spread of research and innovation to health systems decision making. Before running the foundation, he was a professor of health policy analysis at McMaster University in Hamilton, Canada, where in the mid-1980s he co-founded the Centre for Health Economics and Policy Analysis—anglophone Canada’s first applied health services research group.
Harold S. Luft is director of the Palo Alto Medical Foundation Research Institute and Caldwell B. Esselstyn Professor Emeritus of Health Policy and Health Economics at the University of California, San Francisco. He received his degrees in economics from Harvard University. His research has covered HMOs; hospital competition; volume, quality and outcomes of hospital care; risk assessment and risk adjustment; and health care reform. An elected member of the Institute of Medicine, he served on its council, that of the Agency for Health Care Policy and Research (now the Agency for Healthcare Research and Quality), and the board of AcademyHealth. He was co-editor of the journal Health Services Research. His book Total Cure: The Antidote to the Health Care Crisis was published by Harvard University Press in October 2008.
S. Jay Olshansky is a professor in the School of Public Health at the University of Illinois at Chicago. His research is focused on estimating the upper limits to human longevity, the health and public policy implications of individual and population aging, mortality forecasts, pursuing the scientific means to slow aging (the Longevity Dividend), and global implications of the re-emergence of communicable diseases. Major publications include “In Search of Methuselah: Estimating the Upper Limits to Human Longevity” (Science 1990), “If Humans Were Built to Last” (Scientific American 2003), and “A Potential Decline in Life Expectancy in the United States in the 21st Century” (NEJM 2005).
Henry W.W. Potts is a lecturer in the Centre for Health Informatics and Multiprofessional Education at University College London Medical School, where he has been involved in a variety of projects on the socio-technical aspects of health technology systems. He has a particular focus on patient use of the Internet and “Web 2.0” approaches. Drawing on a dual background in psychology and statistics (in which he holds a PhD and an MSc, respectively), he is interested in developing and applying novel study methodologies.
John W. Rowe is a geriatrician with an interest in clinical aspects of aging as well as the policy implications of an aging society. He currently serves as chair of the MacArthur Foundation Research Network on an Aging Society and formerly chaired the foundation’s Research Network on Successful Aging. He is a professor of health policy and management at the Mailman School of Public Health of Columbia University.
Deborah Swinglehurst is a general practitioner (GP), clinical lecturer, and National Institute of Health research trainee, currently pursuing a PhD on the role of the electronic patient record in the primary care consultation under the supervision of Trisha Greenhalgh (University College London [UCL]) and Celia Roberts (King’s College London). She works in the Division of Medical Education at UCL where she is also involved in teaching a web-based master’s program on international primary health care. She continues to work part-time as a GP in Suffolk. Her academic interests include discourse analysis, communication in health care, health informatics, medical education, reflective practice, and evidence-based health care.
Hugh R. Waters is a health economist and associate professor of health policy and management at the Johns Hopkins Bloomberg School of Public Health. Waters has twenty-one years of experience working with public health programs and has worked extensively as a consultant with the World Bank, World Health Organization, and other international organizations. His areas of expertise are health insurance and health financing reforms; evaluation of the effects of health financing mechanisms on access, equity, and quality; and economic evaluation of health programs.
Geoff Wong is a family physician and National Institute of Health clinical lecturer in primary care at University College London (UCL). He is a member of the Royal College of General Practitioners (United Kingdom) and obtained his doctorate of medicine from UCL. His interests are the synthesis of evidence from complex interventions (in particular using realist synthesis) and medical education.
Edward Yelin is a professor in the Department of Medicine and Institute for Health Policy Studies at the University of California, San Francisco. His research focuses on the impacts of severe chronic disease and disability on quality of life, the design of health care systems for persons with chronic disease, and the role of a changing economy in the health of the workforce and in the employment of those with labor market challenges due to health problems. Much of his research concerns persons with severe autoimmune conditions, such as rheumatoid arthritis and systemic lupus erythematosus. He holds a PhD from the University of California, Berkeley.
Yuhui Zheng is a postdoctoral fellow at the RAND Bing Center for Health Economics. Her research interests include health economics, health services research, and health policy. Her previous work has focused on prescription drug cost sharing and drug utilization, economics of obesity, economics of disease prevention and healthy aging, and distributional implications of health care financing in the United States. Her work has been published in journals including the Journal of the American Medical Association, Health Affairs, the American Journal of Public Health, and the American Journal of Preventive Medicine. Zheng holds a PhD.
Read on Wiley Online Library
Read on JSTOR
Volume 87, Issue 4 (pages 927–933)
Published in 2009
In This Issue
Research and Advice Giving: A Functional View of Evidence-Informed Policy Advice In a Canadian Ministry of Health